Idarubicin and pleural effusion Patient Reports February 12, 2012

Idarubicin Side Effects Report #4695094-2
Idarubicin side effect was reported by a Physician from on June 07, 2005. Female patient, 61 years of age, was diagnosed with myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: pleural effusion. Idarubicin dosage: 15 MG, CYCLIC, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient recovered.

Idarubicin Side Effects Report #4711087-0
Idarubicin side effect was reported by a Physician from FRANCE on June 28, 2005. Female patient, 61 years of age, weighting 105.8 lb, was diagnosed with myeloid leukaemia, ill-defined disorder and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: chest wall pain, pleural effusion. Idarubicin dosage: 1.5 GRAM (15 MG, CYCLIC), INTRAVENOUS. During the same period patient was treated with CYTARABINE, METHYLPREDNISOLONE ACETATE, ONDANSETRON, RANITIDINE HYDROCHLORIDE, NEFOPAM. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #4746513-4
Idarubicin side effect was reported by a Physician from FRANCE on Aug 04, 2005. Female patient, 61 years of age, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, ill-defined disorder and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: aplasia, chest wall pain, dyspnoea, heart rate increased, leukaemia, lung disorder, pleural effusion, respiratory rate increased. Idarubicin dosage: 1.5 GRAM (15 MG, CYCLIC), INTRAVENOUS. During the same period patient was treated with CYTATRABINE, METHYLPREDNISONE ACETATE, ONDANSETRON, RANITIDINE HYDROCHLORIDE, NEFOPAM. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5036863-9
Idarubicin side effect was reported by a Health Professional from AUSTRALIA on June 09, 2006. Male patient, 27 years of age, was treated with Idarubicin. After drug was administered, patient experienced the following side effects: enterocolitis, ileus, lung consolidation, metabolic alkalosis, pleural effusion, pyrexia, small intestinal obstruction. Idarubicin dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.